C-1GF4Longevity technology
media, data platform, clinic directory
education media
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-1GF4
C-1GF4C-1GF4media, data platform, clinic directory
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Hosts: Phil Newman: https://qrco.de/bgXpNY Nina Patrick: https://qrco.de/bgXpKn ---------- Sponsor: Fatty15 Fatty15 is a science-backed, patented, award-winning supplement with pure C15:0 that strengthens cell membranes and supports healthy aging at the cellular level. Benefits include deeper sleep, calmer mood, improved energy, and overall wellbeing. Click the link below to learn more and use code UNLOCKED for 15% off the 90-day Starter Kit. Link: https://partners.fatty15.com/UNLOCKED ---------- In this week’s Longevity News Roundup, Phil Newman and Nina Patrick examine wearable health innovation, brain-computer interfaces, physician-led longevity care, Alzheimer’s research, and the evolution of the longevity industry. - ŌURA launched Ring 5, a redesigned device that is 40% smaller while maintaining week-long battery life. New features include blood pressure signals, breathing monitoring, GLP-1 insights, and integrated health data designed to make wearables a central health ma
Hosts: Phil Newman: https://qrco.de/bgXpNY Nina Patrick: https://qrco.de/bgXpKn ---------- Sponsor: Fatty15 Fatty15 is a science-backed, patented, award-winning supplement with pure C15:0 that strengthens cell membranes and supports healthy aging at the cellular level. Benefits include deeper sleep, calmer mood, improved energy, and overall wellbeing. Click the link below to learn more and use code UNLOCKED for 15% off the 90-day Starter Kit. Link: https://partners.fatty15.com/UNLOCKED ---------- In this week’s Longevity News Roundup, Phil Newman and Nina Patrick examine FDA-cleared sleep diagnostics, safer CRISPR therapies, longevity clinic accountability, Retro Biosciences’ valuation, and AI-driven preventative healthcare. - Sunrise received FDA clearance for Sunrise Air, a rechargeable at-home sleep apnea diagnostic using a chin sensor for multi-night testing. The device tracks airflow, oxygen, pulse, and snoring while targeting underdiagnosis linked to cardiovascular and co
Hosts: Phil Newman: https://qrco.de/bgXpNY Nina Patrick: https://qrco.de/bgXpKn ---------- Sponsor: Fatty15 Fatty15 is a science-backed, patented, award-winning supplement with pure C15:0 that strengthens cell membranes and supports healthy aging at the cellular level. Benefits include deeper sleep, calmer mood, improved energy, and overall wellbeing. Click the link below to learn more and use code UNLOCKED for 15% off the 90-day Starter Kit. Link: https://partners.fatty15.com/UNLOCKED ---------- In this week’s Longevity News Roundup, Phil Newman and Dr. Nina Patrick examine pancreatic cancer immunotherapy, GLP-1 gene therapy, immune system rebuilding, cardiovascular plaque reversal and microbiome medicine. -MatterBio filed its first IND application for Lm-LLO-TT, an engineered Listeria-based therapy targeting pancreatic ductal adenocarcinoma. Pending FDA clearance, the company plans a Phase 1/2a study evaluating safety, dosing and early efficacy in advanced pancreatic cancer p
Hosts: Phil Newman: https://qrco.de/bgXpNY Nina Patrick: https://qrco.de/bgXpKn ---------- Sponsor: Fatty15 Fatty15 is a science-backed, patented, award-winning supplement with pure C15:0 that strengthens cell membranes and supports healthy aging at the cellular level. Benefits include deeper sleep, calmer mood, improved energy, and overall wellbeing. Click the link below to learn more and use code UNLOCKED for 15% off the 90-day Starter Kit. Link: https://partners.fatty15.com/UNLOCKED ---------- In this week’s Longevity News Roundup, Phil Newman and Nina Patrick examine GLP-1 drugs in progressive MS, Executive Health as a gateway to longevity care, AI-assisted skin regeneration, lab-grown red blood cells, and convergence in aging biomarkers. - Neuraly’s NLY01 dosed its first Phase 2 patient with progressive MS in the 120-person, 96-week TAGMS trial. Instead of tracking relapse rates, researchers will use MRI-measured brain atrophy as the primary endpoint to determine whether t
Hosts: Phil Newman: https://qrco.de/bgXpNY Nina Patrick: https://qrco.de/bgXpKn ---------- Sponsor: Fatty15 Fatty15 is a science-backed, patented, award-winning supplement with pure C15:0 that strengthens cell membranes and supports healthy aging at the cellular level. Benefits include deeper sleep, calmer mood, improved energy, and overall wellbeing. Click the link below to learn more and use code UNLOCKED for 15% off the 90-day Starter Kit. Link: https://partners.fatty15.com/UNLOCKED ---------- In this week’s Longevity News Roundup, Phil Newman and Nina Patrick examine multi-target Alzheimer's therapy, sugar glycation in aging, personalized CRISPR for Parkinson's, Longevity.Technology partnerships, FDA real-time trials, and peptide platforms. - Longevity.Technology partners with AND Capital Ventures to combine DLT intelligence platform with funding for healthspan startups. It maps hallmarks, biomarkers, and revenue trajectories to scale longevity firms from data to investmen
Find Nina Patrick here: https://qrco.de/bgXpKn ---------- Sponsor: Fatty15 Fatty15 is a science-backed, patented, award-winning supplement with pure C15:0 that strengthens cell membranes and supports healthy aging at the cellular level. Benefits include deeper sleep, calmer mood, improved energy, and overall wellbeing. Click the link below to learn more and use code UNLOCKED for 15% off the 90-day Starter Kit. Link: https://partners.fatty15.com/UNLOCKED ---------- In this week’s Longevity News Roundup, Phil Newman and Nina Patrick examine energy span as a fatigue biomarker, GSK's $950M 35 Pharma acquisition, January AI's Medicare app entry, OsteoBoost's $8M funding, Seragon's SRN-901 33% mouse lifespan boost, and skin longevity advances. - Energy span proposes viewing fatigue as an early mitochondrial decline signal before chronic disease. Advances in wearable technology and continuous monitoring are making it possible to track proxies of energy regulation – heart rate variabilit
Sponsor: Fatty15 Fatty15 is a science-backed, patented, award-winning supplement with pure C15:0 that strengthens cell membranes and supports healthy aging at the cellular level. Benefits include deeper sleep, calmer mood, improved energy, and overall wellbeing. Click the link below to learn more and use code UNLOCKED for 15% off the 90-day Starter Kit. Link: https://partners.fatty15.com/UNLOCKED ---------- In this week’s Longevity News Roundup, Phil Newman and Nina Patrick explore the $67B longevity market projection, Technogym’s Google partnership, Function Health’s acquisition, mitochondrial transplants, clinical education, and the rise of workforce healthspan. A new report projects the longevity and healthy aging market will reach $67B by 2035, spanning therapeutics, diagnostics, supplements, and lifestyle interventions. Growth signals mainstream adoption, but raises concerns around “longevity washing” and the need for stronger scientific validation. Technogym expands its par
Sponsor: Fatty15 Fatty15 is a science-backed, patented, award-winning supplement with pure C15:0 that strengthens cell membranes and supports healthy aging at the cellular level. Benefits include deeper sleep, calmer mood, improved energy, and overall wellbeing. Click the link below to learn more and use code UNLOCKED for 15% off the 90-day Starter Kit. Link: https://partners.fatty15.com/UNLOCKED ______________________ In this week’s Longevity News Roundup, Phil Newman and Nina Patrick examine GeneRare funding, Noom's pharmacy buy, Anovis neuro combos, Life Biosciences reprogramming, wearable partnerships, and Peloton at Longevity Show. - Generare raised $21.6M (€20M) Series A to scale microbial genome scanning for novel natural product molecules, identifying 200+ hits in 2025. Funds expand libraries from plants, fungi, marine sources and team to 50 for bioactive drug leads. AI optimizes hits despite supply/IP challenges, eyeing geroprotectors like rapamycin analogs. - Noom acquir
Sponsor: Fatty15 Fatty15 is a science-backed, patented, award-winning supplement with pure C15:0 that strengthens cell membranes and supports healthy aging at the cellular level. Benefits include deeper sleep, calmer mood, improved energy, and overall wellbeing. Click the link below to learn more and use code UNLOCKED for 15% off the 90-day Starter Kit. Link: https://partners.fatty15.com/UNLOCKED ______________________ In this week’s Longevity News Roundup, Phil Newman and Nina Patrick examine how early neurodegeneration screening, bioprinted tissues, senolytic therapies, pharma strategy shifts, and private clinic evolution are reshaping how longevity medicine is practiced and regulated. - PREMAZ partnered with Health is One to expand access to early brain screening designed to detect neurodegenerative risk before symptoms appear. While full biomarker validation data has not yet been published, the initiative highlights the growing race to identify preclinical Alzheimer’s and deme
Sponsor: Stride Stride helps people understand and improve their wellbeing and longevity through personalised DNA, microbiome, blood biomarker testing, expert guidance, tailored supplements, and actionable insights grounded in robust human science. Click the link below to learn more and use the code 'UNLOCKED' for your 10% discount. Affiliate link: https://www.getstride.com/unlocked/ ____________________ In this week’s Longevity News Roundup, Phil Newman and Nina Patrick explore cutting-edge developments in longevity, from hibernating animals inspiring obesity treatments to AI-driven industry insights and the world’s first Parkinson’s test kit. - FaunaBio identified a metabolic target from hibernating mammals that could preserve muscle during weight loss. The California-based company said the achievement triggers an undisclosed milestone payment as part of a multi-year agreement signed with Lilly in 2023, which could be worth up to $494 million. This will advance this first-in-clas
Sponsor: Stride Stride helps people understand and improve their wellbeing and longevity through personalised DNA, microbiome, blood biomarker testing, expert guidance, tailored supplements, and actionable insights grounded in robust human science. Click the link below to learn more and use the code 'UNLOCKED' for your 10% discount. Link: https://www.getstride.com/unlocked/ ______________________ In this week’s Longevity News Roundup, Phil Newman and Nina Patrick explore new research shaping the future of longevity science, from macrocyclic peptides targeting previously undruggable diseases to hyperbaric oxygen therapy in performance and longevity, and South Korea emerging as a global biotech hub. - Santa Cruz-based Unnatural Products raised $45 million in Series B funding and secured a potential $1.7 billion collaboration with Novartis. The company develops macrocyclic peptide therapeutics, molecules that combine the selectivity of biologics with the cell permeability of small mo
In this week’s Longevity News Roundup, Phil Newman and Dr. Nina Patrick explore the latest breakthroughs shaping longevity and proactive healthcare. From government-backed healthspan trials to next-generation brain wearables, smartphone-based health screening, ovarian longevity research, and nanotech biosensing, this episode connects science, innovation, and real-world impact. - The US government committed $144 million through ARPA-H’s PROSPR program to fund research proving that aging can be treated in humans. Cambrian BioPharma received $30.8 million for trials of a next-generation rapamycin analog, while Linnaeus Therapeutics received $22 million to explore oncology-derived drugs showing age-related benefits. PROSPR also funds biomarker development and trial infrastructure to enable rapid, large-scale healthspan studies. - Temple is developing a head-worn wearable that continuously monitors cerebral blood flow and brain activity. This next-generation device moves beyond wrist-worn
Sponsor: Stride Stride helps people understand and improve their wellbeing and longevity through personalized DNA, microbiome, blood biomarker testing, expert guidance, tailored supplements, and actionable insights grounded in robust human science. Click the link below to learn more and use the code 'UNLOCKED' for your 10% discount. Link: https://www.getstride.com/unlocked/ ______________________ In this week’s Longevity News Roundup, Phil Newman and Dr. Nina Patrick explore the latest breakthroughs shaping healthspan and longevity. From oral GLP-1 pills transforming obesity and metabolic care, to early gene therapy results in aging dogs, and Amazon integrating biomarker-driven longevity insights into primary care, this episode covers innovation, risk, and opportunity across human and animal longevity. - Novo Nordisk and Eli Lilly are moving forward with oral versions of their GLP-1 drugs, potentially bringing millions more patients onto treatment. Pills are easier to access than
In this week’s Longevity News Roundup, Phil Newman and Dr. Nina Patrick explore the latest breakthroughs shaping healthspan and longevity, from new insights into genetic influence on lifespan to reproductive longevity, exosome therapeutics, AI health platforms, epigenetic reprogramming, and psychedelics for cognitive resilience. - New research challenges long-standing estimates of genetic contribution to lifespan. When deaths caused by environmental factors are separated from intrinsic aging, heritability for intrinsic lifespan rises to around 50–55%, doubling previous assumptions and reshaping how we think about early interventions. - Gameto licenses meiosis induction technology from Harvard to create ovarian organoids in a dish, opening a platform for women’s reproductive longevity, drug testing during pregnancy, and potentially improved menopause therapeutics. - Houston-based Prana X Corp raises $17 million to develop exosome-based regenerative biologics, applying techniques initia
The Longevity Show Website: https://longevityshow.com/ The Longevity Show is a science and wellness festival in London focused on healthy aging, cutting‑edge longevity research, practical health‑span strategies, expert talks, and an interactive expo. __________ In this week’s Longevity News Roundup, Phil Newman and Dr. Nina Patrick unpack the biggest stories shaping longevity science and technology, from brain-computer interfaces and AI-driven diagnostics to spaceflight epigenetics and longevity event updates. - Merge Labs, Sam Altman’s BCI startup, launches with funding from OpenAI, exploring next-generation neural interfaces that could merge human cognition with AI. - Lumati introduces an at-home saliva microplastics test, giving individuals a practical way to track environmental exposure and its potential health impacts. - Spaceflight research reveals dynamic DNA methylation changes in astronauts on the Axiom 2 mission, offering fast insights into biological aging and epigenetic
In this week’s Longevity News Roundup, Phil Newman and Dr. Nina Patrick unpack the biggest stories shaping the longevity ecosystem from validated lifestyle science and AI-driven drug discovery to breakthrough clinical trials, CES health tech, and the future of longevity investing. - A new study in the International Journal of Epidemiology confirms that Blue Zone populations still enjoy statistically significant longevity advantages, highlighting the role of community, movement, and diet in healthy aging. - Insilico Medicine made headlines with its Hong Kong IPO, raising $293M and signaling strong investor confidence in AI-driven longevity biotech. The company also secured an $888M oncology collaboration with Servier, marking a major step for AI-powered drug discovery. - At CES, Withings unveiled its at-home Longevity Station, a device that measures 60 biomarkers in just 90 seconds. It tracks cardiovascular function, vascular health, cellular composition, and early cardiometabolic ri
Longevity.Technology UNLOCKED is here! Phil Newman and Dr. Nina Patrick are launching a brand-new series exploring the ideas, science, and stories shaping how we live longer, healthier lives. First episode drops January 5th: GLP-1s – Should We All Be Taking Them?_ with Dr. Jens Juul Holst and Dr. Eric Verdin. Expect real science, clear answers, and practical takeaways you can actually use. Why subscribe now? * Be the first to hear every episode * Get insights from leading experts before they hit the headlines * Learn actionable tips to optimize your healthspan * Join a curious, longevity-minded community #LongevityUnlocked #LongevityPodcast #FutureOfHealth #GLP1 #LongevityTechnology
The longevity industry is no longer a niche—it’s a global economic force. In this episode, Alexia Brue speaks with Phil Newman, founder of Longevity.Technology (https://longevity.technology/) , about how aging science is evolving from the lab into commercial markets. From diagnostics and AI to digital therapeutics and cellular reprogramming, Phil offers a macro view of where capital is flowing, which technologies are gaining traction, and why “healthspan” is the true opportunity of our time. Inside this episode, learn: • How longevity evolved from fringe science to a trillion-dollar opportunity • Why healthspan—not just lifespan—will define the next decade • Why longevity clinics are the new bridge between wellness and clinical care • The 25 sub-domains tracked by Longevity.Technology (e.g. epigenetics, AI diagnostics) • What investors, entrepreneurs, and policymakers need to understand about this fast-moving sector Res
The longevity industry is no longer a niche—it’s a global economic force. In this episode, Alexia Brue speaks with Phil Newman, founder of Longevity.Technology, about how aging science is evolving from the lab into commercial markets. From diagnostics and AI to digital therapeutics and cellular reprogramming, Phil offers a macro view of where capital is flowing, which technologies are gaining traction, and why “healthspan” is the true opportunity of our time. Inside this episode, learn: - How longevity evolved from fringe science to a trillion-dollar opportunity - Why healthspan—not just lifespan—will define the next decade - Why longevity clinics are the new bridge between wellness and clinical care - The 25 sub-domains tracked by Longevity.Technology (e.g. epigenetics, AI diagnostics) - What investors, entrepreneurs, and policymakers need to understand about this fast-moving sector Resources Mentioned: Longevity.Technology To learn more about the Global Wellness Institute please v
Phil Newman, Founder and CEO at Longevity.Technology, delivers the opening remarks at Investing in the Age of Longevity 2024. Introducing the format of the event, which includes a review of "Longevity Next" and "Longevity Now", Phil gives an overview of the longevity market, including the sector's past and current financing environment. He also shares Longevity.Technology's new 10-level classification for analysing the industry, and outlines the trends and investment opportunities that each level entails. Find out more about past and upcoming Master Investor webinars: https://events.masterinvestor.co.uk Keep in touch: Substack | https://masterinvestoruk.substack.com Newsletter | https://masterinvestor.co.uk/subscribe Twitter | https://twitter.com/masterinvestor Facebook | https://facebook.com/masterinvestor LinkedIn | https://linkedin.com/company/masterinvestor TikTok | https://www.tiktok.com/@masterinvestoruk
Longevity.Technology’s CEO Phil Newman tests his healthspan at a state-of-the-art clinic. Longevity clinics are rapidly emerging as essential destinations for individuals invested in prolonging their health and vitality. With state-of-the-art equipment and a growing emphasis on holistic well-being, these clinics cater to those seeking to optimize their healthspan – the period of life spent in good health, free from chronic diseases and disabilities. Long gone are the days when healthcare was solely about treating illnesses – now, it is about proactive measures to prevent them. Regular visits to these clinics are becoming routine for longevity enthusiasts, integrating seamlessly into their health regimens. Whether it's an annual check-up or more regular tracking of biomarkers and other diagnostics, these appointments serve as proactive steps towards understanding and enhancing one's healthspan by investigating everything from microbiomes to cognitive decline. It's no longer just about
Live recording from the talk "Longevity megatrend" presented by Phil Newman and hosted by Oxford Society of Ageing and Longevity. Why advances in science, macro-economic trends, and the basic desire of every human to want to live a long and healthy life, is creating the world’s biggest industry. In his talk, Phil Newman, the Founder and CEO of Longevity.Technology, will explain what the longevity market is, highlight key scientific advances, explore the latest financial data, and look to the future of an exciting industry that is attracting both talent and investment capital. $7.3bn was invested into longevity companies last year - doubling the amount invested in the previous year. Longevity has fast become a distinct business and investment category – this is your chance to get the inside track. Phil Newman is Founder and CEO of www.Longevity.Technology the leading media and investment platform targeting the longevity sector. In his career he has held c-level management positions
The Rising of the Longevity Market | James Strole and Phil Newman, for RAADfest 2022 Phil Newman, Longevity.Technology CEO, chats with James Strole, Executive Director of the Coalition for Radical Life Extension, about what he's bringing to RAADfest 2022. Phil is Editor-in-Chief of www.Longevity.Technology and founder of First Longevity a digital investment platform for international investors and longevity start-ups. In his career he has held c-level management positions; applying his marketing and business development expertise into: longevity, IoT, AI, medical devices, biopharma, 3D manufacturing, smartgrid and sustainability. Hear what he has to share, and meet him at RAADfest 2022, October 6-9, in San Diego, CA For more info: http://www.raadfest.com Organized by the Coalition for Radical Life Extension, RAADfest is the largest event in the world where practical and cutting-edge methods to reverse aging are presented for all interest levels, from beginner to expert. An inter
- YouTube Info Presse Urheberrecht Kontakt Creator Werben Entwickler Impressum Verträge hier kündigen Nutzungsbedingungen Datenschutz Richtlinien & Sicherheit Wie funktioniert YouTube? Neue Funktionen testen © 2026 Google LLC
Longevity.Technology: como uma empresa de IA quer transformar envelhecimento saudável em dado útil - Toque Tec menu Menu Principal Tecnologia & Inovação Lançamentos Lar Inteligente Saúde & Bem-Estar Vida Prática Escolha Certa Cuidado em Família Na Garagem DropsTec Casa Pet Friendly Mundo WAP Apoio Sobre nós Contato Login --> Colunas E a IA? PopTec LifesTec Redes Sociais Tecnologia & Inovação Lançamentos Lar Inteligente Saúde & Bem-Estar Vida Prática Escolha Certa Cuidado em Família Na Garagem DropsTec Casa Pet Friendly Mundo WAP Sobre nós Contato Login --> E a IA? PopTec LifesT
First Longevity announces first investors for current round - Longevity.Technology Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search Vasa Thera … interested: Email ... or meeting booking link Some news of our own: European VC fund and a Longevity innovator participate in the First Longevity funding round. Last week we announced that Tom Britton joined our Advisory Panel as plans for our Longevity equity funding platform take another step forward. Today we’re pleased to announce a six-figure investment in our current funding round for First Longevity. We are now putting our new investors’ cash to work whilst still … icipating in this first stage are Chairman, George Sutherland and Longevitytech.fund a new European Longevity-focused fund based in the Czech Republic. Petr Sramek (pictured), Co-founder, Chairman and Managing Partner of Longevitytech.fund, commented: “Success is a function of perfect timing, strategic position, and the team. These are exactly the ingredients we like about the First Longevity business plan.” “There is exceptional progress in the science of u … ’s greatest and most ethical investment opportunity.” Longevitytech.fund has already invested in another UK business, Agecurve , and with more investors entering the Longevity sector, we were interested in understanding the indicators that Petr is experiencing to demonstrate growth of the Longevity market, he told us: “There is exceptional progress in the science of understanding aging and at the same time it is also probably the world’s greatest and m … of First Longevity Ltd, commented: “It’s great to have Petr and his fund as an early investor and together with myself and another key investor who’s well-known in the Longevity field, we are making important steps forward while we continue with the round. While we do have commitment from other key Longevity investors, we would
Longevity biotech IPO: Genflow to become Europe’s first; float expected later this month. LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedI … moving into clinical trials as soon as next year, the company is now seeking to fund its progress by joining the exclusive club of publicly traded longevity biotech companies. I’ll be following Genflow’s progress with interest. Genflow says that the float on the LSE is expected to happen “in the next few weeks” and will value the company at around £23.4m. The company says it has raised £3.7m in an oversubscribed placing, conditional upon admission becoming effective. The comp … s ago The company is backed by investors including Jim Mellon and Longevitytech.fund , Genflow is also supported by a strong advisory board, including the likes of The Buck Institute’s Dr Eric Verdin and the University of Rochester’s Dr Vera Gorbunova . Read the full article here. Disclosure: I am the CEO of First Longevity Ltd which is a shareholder in Genflow Biosciences Ltd. Longevity.Technology Longevity.Technology 9,688 followers + Subscribe Like Like Celebrate Support L
First Longevity Ltd Asset Profile | Preqin Skip to main content Products Our products Preqin Pro Alternative assets data platform Private Markets Research Industry research Term Intelligence Benchmark LPA terms Preqin Benchmarks Industry's leading performance data Preqin Sustainability ESG data and insights Company Intelligence Companies & deals data Enterprise Data Solutions Flexible data delivery solutions Transaction Intelligence A $5.4tn transaction repository Client stories What our clients say Quick Links Our data Asset classes we cover Create a free account Newsletter Contribut … r analysis Keep up with market trends Spot new business opportunities Benchmark fund terms Navigate private credit investing Quick Links Our data Asset classes we cover Create a free account Newsletter Contribute data Contact us Insights+ Private markets research Homepage Browse reports Search Search the research library Webinar recordings Join conversations with our analysts Meet the analysts Meet the team behind the reports Learn more Learn more about Private Markets Resear … r analysis Keep up with market trends Spot new business opportunities Benchmark fund terms Navigate private credit investing Insights+ Homepage Search Webinar recordings Meet the analysts Learn more News & content Homepage Events Free Benchmarks Data coverage map Preqin Profiles Preqin Academy Compensation calculator About Who we are Our corporate responsibility Partners Press hub Careers Contact us QuickLinks Our data Asset classes we cover Create a free account Newslett … ed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers. Request demo First Longevity Ltd - overview Established 1997 Location London, England, UK Primary Industry Biotechnology About First Longevity Ltd is a health-focused investment platform connecting investors with innovative projects in the longevity and wellness sectors, facilitating funding for transformative health i … go Pro Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more. Sign in Request demo Our Company Who We Are Our Corporate Responsibility Partners
--> Phil Newman | Longevity Investors top of page HOME EVENTS LIC in Gstaad 2026 LIC in Gstaad 2025 LIC in Gstaad 2024 LIC in Gstaad 2023 LIC in Gstaad 2022 LIC (Virtual) 2021 LIC (Virtual) 2020 LIL in Davos 2026 LIL in Davos 2025 LIL in Davos 2024 LIL in Davos 2023 LIL in Davos 2022 XPRIZE Investor Summit 2025 TEAM PRESS LI News CONTACT More Use tab to navigate through the menu items. < Back Phil Newman Founder, First Longevity, Editor-in-Chief Longevity.Technology Next As Editor-in-Chief of Longevity.Technology Phil oversees daily news and market research to address the crossover between
Phil Newman HOME REPLAYS DEMOZONE SPEAKERS ABOUT US en fr PN Phil Newman Longevity.Technology CEO & Founder Description Phil Newman is Founder and CEO of www.Longevity.Technology the leading media and consumer brand supporting the longevity megatrend. In his career he has held multiple c-level management positions; applying his marketing and business development expertise into: longevity, IoT, bionics, medical devices, biopharma, 3D manufacturing, smartgrid and sustainability. In 2018 he saw an opportunity in the emerging longevity field to create a media platform that addressed science, busin
Rubedo Life Sciences expands its Scientific Advisory Board Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search Vasa Therapeutics to presen... New … ospital in Boston, MA, an internship in General Surgery at Cleveland Clinic and residency in dermatology at The University of Chicago, IL. He received his MD degree from Javeriana University in Bogota, Colombia, where he grew up. Dr Lacouture began his career in Oncodermatology at The University of Chicago. During his first faculty appointment at Northwestern University, Dr Lacouture received a Zell Scholarship and a Career Development Award from the Dermatology Foundation, a
Longevity and Healthspan Daily Highlights | Longevity.Technology posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to L … d it’s worth understanding why. Dimethyl sulfoxide has one FDA-approved medical application: treating interstitial cystitis. Outside that use, a meta-analysis (Brien et al.) examined DMSO for osteoarthritis and concluded it was not clinically effective for pain reduction. Yet preclinical data keeps generating interest. A 2017 Neuropharmacology study (Penazzi et al.) found chronic low-dose DMSO improved memory and behavioral outcomes in an Alzheimer’s mouse model. Separately,
AI model predicts disease risk with UK and Danish data. | Longevity.Technology posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, … for example, take the brakes off the immune system to help it fight cancer, or apply the brakes to calm it down in autoimmune diseases . The future of medicine is moving beyond just external drugs. It's about mastering the body's own intelligent systems to help it heal itself. #NobelPrize #Immunotherapy #CancerResearch #ScienceMadeSimple #Immunology #FutureOfMedicine 7 Like Comment Share Copy LinkedIn Facebook X To view or add a comment, sign in Flaria El Khoury 8mo Edited R … n in Soapbox 6,943 followers 8mo Report this post 📣 Owlstone Medical wins £36m award from Advanced Research Projects Agency for Health (ARPA-H) to develop at-home cancer detection tests 𝗥𝗲𝗮𝗱 𝗺𝗼𝗿𝗲 ⤵️ ⚙️ Medical 📈 Grant 💰 £36m 🤝 Advanced Research Projects Agency for Health (ARPA-H) 🧑 Billy Boyle ; David Ruiz Alonso 🌎 Cambridge, United Kingdom 🔗 𝗶𝗻 𝗰𝗼𝗺𝗺𝗲𝗻𝘁𝘀 2 2 Comments Like Comment Share Copy LinkedIn Facebook X To view or add a comment, sign in America
Longevity News: Generare Raises $21.6M, Allergan Aesthetics Drives Growth | Longevity.Technology posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to … tech Networks 25,843 followers 1mo Report this post SDBN Feed: $13 Million CIRM Award to Fund Research on the Role of RNA Pollution in Neurodegenerative Diseases https://lnkd.in/gzPVVF3s UC San Diego has received a $13 Million grant from the California Institute for Regenerative Medicine (CIRM) to investigate how RNA pollution drives neurodegenerative diseases and to develop novel therapies that protect the aging brain. Click here to view original post Click Here to Publish/F … ish/Feature Your Company or Product News with Biotech Networks $13 Million CIRM Award to Fund Research on the Role of RNA Pollution in Neurodegenerative Diseases https://sdbn.org 1 Like Comment Share Copy LinkedIn Facebook X To view or add a comment, sign in Dr. Diego Mendoza 1mo Report this post The geroscience hypothesis is no longer theoretical — clinical evidence now supports targeting aging itself as the primary strategy against chronic disease. 📋 New Research — Rapamyc
A Policymakers Guide to the Longevity Therapeutics Industry - Alliance for Longevity Initiatives Skip to content Dr. Mehmet Oz’s Opening Remarks at A4LI’s 2025 Congressional Briefing Join A4LI Become a Member Become a Sponsor Get Involved Our Advocacy Publications Longevity Science Caucus Podcasts H-SPAN Podcast Scientific Spotlights About Events A4LI H-SPAN Summit D.C. Past Events A4LI Longevity Investors Summit A4LI 2025 D.C. Summit Recap DC Fly-In 2024 Geroscience Education Reception LogIn Join A4LI Become a Member Become a Sponsor Get Involved Our Advocacy Publications Longevity Science Ca … a Therapeutics, Dr. Freund has secured over $50M in financing and pioneered the application of targeted biologics to deplete the pathogenic cells that drive chronic diseases and aging. Previously, as a senior leader at Calico Life Sciences, Dr. Freund founded and managed an R&D team with the mission of merging computational and experimental biology to develop interventions that slow or reverse aspects of aging. He launched and led several therapeutic programs, notably spe … s Fiona Miller is a Managing Partner at quadraScope Ventures, a venture capital fund focusing on early-stage investments in the longevity biotechnology sector. She is a serial entrepreneur with over 40 years of experience in technology entrepreneurship and venture capital, previously founding and leading three technology companies to successful exits. Natalia Mitin CEO Sapere Bio Dr. Natalia Mitin is the co-founder, president, and CEO of Sapere Bio, a longevity technology com … etta and Arivale. His many national and international awards include the Lasker Prize, the Kyoto Prize, and the National Medal of Science. Currently, he is the CEO of Phenome Health, Co-Founder and Professor at the Institute of Systems Biology in Seattle, and Co-Director, Center for Human Healthspan, Chief Innovation Officer and Distinguished Professor at the Buck Institute for Research on Aging. Koji Tanabe, PhD Founder and CEO I Peace Inc. Dr. Koji Tanabe is the Founder, an … eace, Inc. I Peace, Inc. is a Palo Alto-based biotech startup focusing on Nobel Prize-winning technology of induced pluripotent stem cells (iPSCs) and has successfully developed a novel system to mass manufacture clinical-grade iPSCs for cell therapy in a palm-sized closed cassette. I Peace supports research institutions and pharmaceutical compan
Nina Ruge announced as chair of Rejuvenation Startup Summit 2024's longevity panel Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search Vasa
Longevity Sector Advances with Biomarkers, Therapies and Patents | Longevity.Technology posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or
Healios to fast-track pluripotent stem cell therapy - Longevity.Technology Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search Vasa Therapeutics … velopment of innovative medicines and, where possible, accelerate the practical application of off label life saving medications to the wider audience. Alongside this, Healios is developing a proprietary gene modified iPSC Platform of non-immunogenic, off-the-shelf (allogenic) ‘Universal Donor Cells’ for applications in next-generation therapies in ophthalmology, organ regeneration, and immuno-oncology. This includes the development of iPSC derived gene-modified natural kille
#future #ai #biology #longevity #aging | Logan Thrasher Collins LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement , Priva … ch and longevity technology. I also helped my workshop team win $10,000 for our proposal on using AI to decode cellular differentiation trajectories! #future #ai #biology #longevity #aging https://lnkd.in/g48J-z6R +5 40 6 Comments Like Comment Share Copy LinkedIn Facebook X Nolan Shafik 1y Report this comment It was a pleasure meeting you! I am excited to see what the future holds for us both. Like Reply 2 Reactions 3 Reactions Ben M. 1y Report this comment Excited
About us - the Longevity.technology team and advisory board Skip to content News Data Podcast Clinics News Data Podcast Clinics Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics About Contact About Contact Advertise nEWSLETTER MEDIA Longevity.Technology has rapidly become the #1 global destination for professionals, innovators, and investors seeking to explore the intersection of science, technology, and business in the longevity sector. By building comprehensive datasets and fostering relationships within the industry, Longevity.Technology has positioned itself as a piv … Director Tom is the co-founder of SyndicateRoom, a data driven venture capital fund which is a leading UK platform for professional and retail investors. He has an MBA from Cambridge and is an active business angel investing in early-stage venture startups. Linkedin Facebook Instagram Youtube X-twitter Quick links Advertise Newsletter Contact More from Longevity.Technology NEWS DATA PODCAST CLINICS Copyright 2026 © First Longevity Ltd. All rights reserved. Privacy Policy Coo
Big news in the longevity field and Longevity Technology - ARDD will run in Boston (Oct 2-3, 2026, Joseph B. Martin Conference Center at Harvard Medical School) with Vadim Gladyshev as executive… | Alex Zhavoronkov | 17 comments LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update yo
Longevity.Technology UNLOCKED | Phil Newman LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement , Privacy Policy , and Cook
Phil Newman Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search New CTO joins Rokit Healthc... MitoRx’s new obesity ... Muna Therapeutics&#
Episode 103 - Longevity.techno… - Joint Dynamics Podcast - The Intelligent Movement Series - Apple 팟캐스트 검색 홈 신규 인기 차트 검색 2024년 6월 24일 1시간 28분 Episode 103 - Longevity.technolgy with Phil Newman Joint Dynamics Podcast - The Intelligent Movement Series 재생 Send us Fan Mail Phil Newman is Editor-in-Chief at Longevity.Technology and founder of First Longevity which brings together international investors and Longevity start-ups. In his career, Phil has held c-level management positions; applying his marketing and business development expertise into these tech sectors: Longevity; IoT; AI; Medical Dev
Rejuvenation Startup Summit 2022 announces Program and Speakers - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press R … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Rejuvenation Startup Summit 2022 announces Program and Speakers September 15, 2022 | 4 min read Twitter LinkedIn Facebook Email Print The Forever Healthy Foundation is pleased to announce the Rejuvenation Startup Summit 2022 program and full speaker list. BERLIN, Sept. 15, 2022 (GLOBE NEWSWIRE) -- The Forever Healthy Fo … startups turning research on the root causes of aging into therapies for human application. Learn more at https://www.forever-healthy.org . Media Contact for Forever Healthy Frank Schueler, Chief Operating Officer [email protected] Twitter LinkedIn Facebook Email Print Events Healthcare Europe LATEST Opinion Local trade groups must support life sciences in these difficult times June 10, 2026 · 4 min read · Jennifer Hawks Bland Mergers & … lero Obesity ADA: Novo boasts deep pipeline, ‘breadth of assets’ after analysts award Lilly weight loss gold June 8, 2026 · 5 min read · Heather McKenzie Weight loss ADA: Kailera ‘back at work’ after record-breaking IPO with China data in hand June 8, 2026 · 4 min read · Annalee Armstrong FDA Busy FDA gives rare disease sector complementary pathways, unanswered questions June 8, 2026 · 8 min … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Rejuvenation Startup Summit 2024 announces first set of speakers - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Rejuvenation Startup Summit 2024 announces first set of speakers November 8, 2023 | 5 min read Twitter LinkedIn Facebook Email Print Join the largest in-person gathering of CEOs from the worldwide Rejuvenation & Longevity biotech sector Join the largest in-person gathering of CEOs from the worldwide Rejuvenation &am … e Healthy Longevity Clinic and Managing Partner of LongevityTech.fund Brian Kennedy, Professor at the National University of Singapore Eric Verdin, CEO and president of the Buck Institute for Research on Aging Investors on stage: Jens Eckstein, Investment Partner at Hevolution Alex Colville, Co-Founder, General Partner at Age1 Jan Adams, Partner at Apollo Health Ventures Sergey Jakimov, Managing Partner at LongeVC Marc P. Bernegger, Founding Partner … lero Obesity ADA: Novo boasts deep pipeline, ‘breadth of assets’ after analysts award Lilly weight loss gold June 8, 2026 · 5 min read · Heather McKenzie Weight loss ADA: Kailera ‘back at work’ after record-breaking IPO with China data in hand June 8, 2026 · 4 min read · Annalee Armstrong FDA Busy FDA gives rare disease sector complementary pathways, unanswered questions June 8, 2026 · 8 min … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Longevity clinics around the world are selling unproven treatments | MIT Technology Review You need to enable JavaScript to view this site. Skip to Content MIT Technology Review Featured Topics Newsletters Events Audio MIT Technology Review Featured Topics Newsletters Events Audio Biotechnology and health Longevity clinics around the world are selling unproven treatments A survey of 82 clinics around the world reveals the messy state of longevity medicine. By Jessica Hamzelou archive page April 18, 2025 Adobe Stock The quest for long, healthy life—and even immortality—is probably almost as old
Prema Cognition secures backing for earlier dementia detection Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search Vasa Therapeutics to presen...
Top European longevity clinics set to present at Rejuvenation Startup Summit 2024 Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search Vasa Therap … d Praque. Sramek, a lifelong entrepreneur and Managing Partner of LongevityTech.fund, co-founded the Healthy Longevity Clinic in 2021 to provide access to cutting-edge therapies and diagnostics faster than it is usual in the often-rigid healthcare industry. While expanding fund portfolio companies, the clinic established a path to allow their clients to get access to these therapies years earlier than in any other place in the world. The Summit will feature an all-day Startup
Biotech Archives - Page 157 of 175 - Longevity.Technology Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search Muna Therapeutics’ Al... Celu
Exclusive investor-only Longevity conference announced - Longevity.Technology Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search Vasa Therapeuti … Asset Managers. As well as a focus on the most relevant Longevity investors and fund activity, sub-topics include life-extension and cryonics. “The longevity industry is highly attractive for investors. We see a lack of education and information for investors and want to change this …” Co-organiser Dr Tobias Reichmuth is excited by the plan: “The longevity industry is highly attractive for investors. We see a lack of education and information for inves
Instagram Instagram Log In Sign Up Close Never miss a post from longevity.technology Sign up for Instagram to stay in the loop. Sign up Log in longevity.technology • Follow Original audio More options longevity.technology 1w Retro Biosciences Hits 1.8B ㅤ Retro Biosciences, backed by OpenAI CEO Sam Altman, has reached a $1.8B valuation following a new funding round. The company has also initiated its first clinical trial testing an oral drug aimed at clearing protein clumps linked to Alzheimer’s disease. ㅤ Full Episode on YouTube, Spotify and Apple Podcast. Link in the bio. ㅤ #LongevityTechnolo
Fast-mimicking diet: benefits, side effects and how to get started Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search FibroBiologics begins huma
Sam Altman's $1.8B Longevity C…–Longevity.Technology UNLOCKED – Apple Podcasts Search Home New Top Charts Search 29 May 24 min Sam Altman's $1.8B Longevity Company, CRISPR & AI Health | Longevity News Roundup — Week 22, 2026 Longevity.Technology UNLOCKED Play Hosts: Phil Newman: https://qrco.de/bgXpNY Nina Patrick: https://qrco.de/bgXpKn ---------- Sponsor: Fatty15 Fatty15 is a science-backed, patented, award-winning supplement with pure C15:0 that strengthens cell membranes and supports healthy aging at the cellular level. Benefits include deeper sleep, calmer mood, improved energy, and
Longevity.Technology UNLOCKED - Podcast - Apple Podcasts Search Home New Top Charts Search Longevity.Technology UNLOCKED Longevity.Technology 5.0 (3) Health & Fitness Updated Weekly Longevity.Technology UNLOCKED brings together science, business, and human potential to explore the frontier of longer, healthier living. 🎙 Mondays: In-depth conversations with scientists, founders, investors, operators, and elite performers shaping the longevity ecosystem. 🧠 Fridays: A sharp weekly round-up of the biggest stories, trends, and insights from across the longevity space. If you’re curious about … co.de/bgXpKn ---------- Sponsor: Fatty15 Fatty15 is a science-backed, patented, award-winning supplement with pure C15:0 that strengthens cell membranes and supports healthy aging at the cellular level. Benefits include deeper sleep, calmer mood, improved energy, and overall wellbeing. Click the link below to learn more and use code UNLOCKED for 15% off the 90-day Starter Kit. Link: https://partners.fatty15.com/UNLOCKED ---------- In this week’s Longevity News Roundup, Phil N … co.de/bgXpKn ---------- Sponsor: Fatty15 Fatty15 is a science-backed, patented, award-winning supplement with pure C15:0 that strengthens cell membranes and supports healthy aging at the cellular level. Benefits include deeper sleep, calmer mood, improved energy, and overall wellbeing. Click the link below to learn more and use code UNLOCKED for 15% off the 90-day Starter Kit. Link: fatty15.com/UNLOCKED ---------- Guests: Jenny Duan Co-Founder and CEO of Clair Health LinkedIn … co.de/bgXpKn ---------- Sponsor: Fatty15 Fatty15 is a science-backed, patented, award-winning supplement with pure C15:0 that strengthens cell membranes and supports healthy aging at the cellular level. Benefits include deeper sleep, calmer mood, improved energy, and overall wellbeing. Click the link below to learn more and use code UNLOCKED for 15% off the 90-day Starter Kit. Link: https://partners.fatty15.com/UNLOCKED ---------- In this week’s Longevity News Roundup, Phil N … vascular plaque reversal and microbiome medicine. MatterBio filed its first IND application for Lm-LLO-TT, an engineered Listeria-based therapy targeting pancreatic ductal adenocarcinoma. Pending FDA clearance, the company plans a Phase 1/2a study evaluating safety, dosing and early efficacy in advanced pancreatic cancer patients resistant to con
Sam Altman's $1.8B Longevity C… — Longevity.Technology UNLOCKED — Apple Podcasts Buscar Início Novidades Top charts Buscar 29 de maio 24 min Sam Altman's $1.8B Longevity Company, CRISPR & AI Health | Longevity News Roundup — Week 22, 2026 Longevity.Technology UNLOCKED Reproduzir Hosts: Phil Newman: https://qrco.de/bgXpNY Nina Patrick: https://qrco.de/bgXpKn ---------- Sponsor: Fatty15 Fatty15 is a science-backed, patented, award-winning supplement with pure C15:0 that strengthens cell membranes and supports healthy aging at the cellular level. Benefits include deeper sleep, calmer mood,
News - Longevity.Technology Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search Vasa Therapeutics to presen... New CTO joins Rokit Healthc... Mit
The longevity diet: how it works, benefits and side effects Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search FDA approves new therapy fo... ŌU
Longevity nutrition firm lands Mubadala funding for 'global expansion' Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search FDA approves
Eat your way to a longer life with Valter Longo's longevity diet breakfast ideas Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search HAYA Th
Valter Longo: Can Short Fasting Cycles Regenerate the Body? - Longevity.Technology UNLOCKED Skip to content NEWS DATA PODCAST CLINICS NEWS DATA PODCAST CLINICS HOME CONTACT BECOME A GUEST HOME CONTACT BECOME A GUEST Advertise NEWS DATA PODCAST CLINICS NEWS DATA PODCAST CLINICS HOME CONTACT BECOME A GUEST HOME CONTACT BECOME A GUEST Advertise Back to all episides May 18, 2026 Interview Valter Longo: Can Short Fasting Cycles Regenerate the Body? What if a five-day diet could reset metabolism, regenerate tissue, and challenge decades of nutrition dogma? Phil Newman and Dr. Nina Patrick sit down w … ttps://valterlongo.com/ Sponsor: Fatty15 Fatty15 is a science-backed, patented, award-winning supplement with pure C15:0 that strengthens cell membranes and supports healthy aging at the cellular level. Benefits include deeper sleep, calmer mood, improved energy, and overall wellbeing. Click the link below to learn more and use code UNLOCKED for 15% off the 90-day Starter Kit. Link : fatty15.com/UNLOCKED Connect with our Hosts: Phil Newman Founder and CEO of Longevity.Technol
--> Dr Valter Longo Archives - Longevity Clinics Terms & Conditions By submitting this form, you agree to the following: The information you provide will be collected and used by our team to match you with longevity clinics and programs aligned with your needs. Your data may be securely stored, processed, and used for internal service improvements and program development. Your details may be shared, on a strictly confidential basis, with carefully vetted clinics and partners. Your data may be transferred outside the EU/UK with appropriate safeguards in place. You may withdraw consent or re
The case for fasting as regenerative medicine Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search FDA approves new therapy fo... ŌURA’s sma
Valter Longo: Can Short Fastin... - Longevity.Technology UNLOCKED - Apple Podcasts Cerca Home Novità Classifiche Cerca 18 maggio 1h 3min Valter Longo: Can Short Fasting Cycles Regenerate the Body? Longevity.Technology UNLOCKED Riproduci Hosts: Phil Newman: https://qrco.de/bgXpNY Nina Patrick: https://qrco.de/bgXpKn ---------- Sponsor: Fatty15 Fatty15 is a science-backed, patented, award-winning supplement with pure C15:0 that strengthens cell membranes and supports healthy aging at the cellular level. Benefits include deeper sleep, calmer mood, improved energy, and overall wellbeing. Click t
On Longevity Technology, Professor... - Prof. Valter Longo Facebook Вход Публикация Prof. Valter Longo Prof. Valter Longo Подтвержденный аккаунт 29 январь 2022 г. · Поделился/-ась с Доступно всем On Longevity Technology, Professor Longo talks about diet, exercise, and especially fasting and how it should be conducted with proper care and attention. For more information, read the article at the following link https://www.longevity.technology/valter-longo-everybodys.../ #ProfValterLongo #longevitydiet #fastiningmimickingdiet #longevitytechnology и ещё 3 Create Cures Foundation 29 январь 2022 г.
Sam Altman's BCI startup Merge Labs launches with funding from OpenAI Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search HAYA Therapeutics
OpenAI CEO invested $180 million in longevity company Retro Bio Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search FDA approves new therapy fo..
UNLOCKED Podcast | The Science, Business & Future of Longevity Skip to content NEWS DATA PODCAST CLINICS NEWS DATA PODCAST CLINICS HOME CONTACT BECOME A GUEST HOME CONTACT BECOME A GUEST Advertise NEWS DATA PODCAST CLINICS NEWS DATA PODCAST CLINICS HOME CONTACT BECOME A GUEST HOME CONTACT BECOME A GUEST Advertise The podcast shaping the future of longevity. Available on Spotify Apple Youtube Episode notes Could Banking Your Cells Today Add Healthy Years Tomorrow? June 8, 2026 Episode notes > Are Brain Interfaces Finally Ready For Daily Life? | Longevity News Roundup — Week 23, 2026 June
--> Sam Altman Archives - Longevity.Technology Log in or apply to view this content. Login Apply Oops! We could not locate your form. Annual longevity investment report 2023 Purchase report $59.99 Purchase report $59.99 Login to read (requires purchase) First half longevity investment report 2024 Purchase report $29.99 Purchase report $29.99 Login to read (requires purchase) Feedback Store News Lifestyle Events --> About Contact Advertise --> About Contact Advertise News Investment Clinics Search for: Search News Home Biotech Investment Diagnostics Agetech Supplements Innovation AI/Digital Eco
Longevity.Technology UNLOCKED - ポッドキャスト - Apple Podcast 検索 ホーム 新着おすすめ トップランキング 検索 Longevity.Technology UNLOCKED Longevity.Technology 0.0（0） 健康／フィットネス アップデート：毎週 Longevity.Technology UNLOCKED brings together science, business, and human potential to explore the frontier of longer, healthier living. 🎙 Mondays: In-depth conversations with scientists, founders, investors, operators, and elite performers shaping the longevity ecosystem. 🧠 Fridays: A sharp weekly round-up of the biggest stories, trends, and insights from across the longevity space. If you’re curious about the future of health, perf … co.de/bgXpKn ---------- Sponsor: Fatty15 Fatty15 is a science-backed, patented, award-winning supplement with pure C15:0 that strengthens cell membranes and supports healthy aging at the cellular level. Benefits include deeper sleep, calmer mood, improved energy, and overall wellbeing. Click the link below to learn more and use code UNLOCKED for 15% off the 90-day Starter Kit. Link: https://partners.fatty15.com/UNLOCKED ---------- In this week’s Longevity News Roundup, Phil N … co.de/bgXpKn ---------- Sponsor: Fatty15 Fatty15 is a science-backed, patented, award-winning supplement with pure C15:0 that strengthens cell membranes and supports healthy aging at the cellular level. Benefits include deeper sleep, calmer mood, improved energy, and overall wellbeing. Click the link below to learn more and use code UNLOCKED for 15% off the 90-day Starter Kit. Link: fatty15.com/UNLOCKED ---------- Guests: Jenny Duan Co-Founder and CEO of Clair Health LinkedIn … co.de/bgXpKn ---------- Sponsor: Fatty15 Fatty15 is a science-backed, patented, award-winning supplement with pure C15:0 that strengthens cell membranes and supports healthy aging at the cellular level. Benefits include deeper sleep, calmer mood, improved energy, and overall wellbeing. Click the link below to learn more and use code UNLOCKED for 15% off the 90-day Starter Kit. Link: https://partners.fatty15.com/UNLOCKED ---------- In this week’s Longevity News Roundup, Phil N … vascular plaque reversal and microbiome medicine. MatterBio filed its first IND application for Lm-LLO-TT, an engineered Listeria-based therapy targeting pancreatic ductal adenocarcinoma. Pending FDA clearance, the company plans a Phase 1/2a study evaluating safety, dosing and early efficacy in advanced pancreatic cancer patients resistant to con
Sam Altman's $1.8B Longevity Company, CRISPR & AI Health | Longevity News Roundup — Week 22, 2026 - Longevity.Technology UNLOCKED Skip to content NEWS DATA PODCAST CLINICS NEWS DATA PODCAST CLINICS HOME CONTACT BECOME A GUEST HOME CONTACT BECOME A GUEST Advertise NEWS DATA PODCAST CLINICS NEWS DATA PODCAST CLINICS HOME CONTACT BECOME A GUEST HOME CONTACT BECOME A GUEST Advertise Back to all episides May 29, 2026 News Roundup Sam Altman’s $1.8B Longevity Company, CRISPR & AI Health | Longevity News Roundup — Week 22, 2026 In this week’s Longevity News Roundup, Phil Newman and … e-early-with-ai/ Sponsor : Fatty15 Fatty15 is a science-backed, patented, award-winning supplement with pure C15:0 that strengthens cell membranes and supports healthy aging at the cellular level. Benefits include deeper sleep, calmer mood, improved energy, and overall wellbeing. Click the link below to learn more and use code UNLOCKED for 15% off the 90-day Starter Kit. Link : fatty15.com/UNLOCKED Hosts: Phil Newman Founder and CEO of Longevity.Technology Dr. Nina Patr
Instagram Instagram Log In Sign Up Close Never miss a post from longevity.technology Sign up for Instagram to stay in the loop. Sign up Log in Tags retrobiosciences longevity.technology • Follow More options longevity.technology 1w Sam Altman-backed longevity startup moves deeper into human testing as investors bet big on the future of healthier aging. ㅤ Link in bio. ㅤ #longevity #biotech #healthieraging #clinicaltrials #geroscience Load more comments No comments yet. Start the conversation. Like 9 Comment Share Save May 27 Log in to like or comment. More posts from longevity.technology Clip C
Longevity.Technology Skip to content News Data Podcast Clinics News Data Podcast Clinics Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics About Contact About Contact Advertise nEWSLETTER Your daily longevity briefing Sign-up to our free daily newsletter for the latest longevity science, investment, innovation and insights. Email Address (Required) This field is hidden when viewing the form Contact Source CAPTCHA Latest Articles Biotech Rejuvenate Bio secures funding and Merck partnership Biotech If you could freeze a healthier version of yourself… Biotech Data raises qu
FDA fast-tracks RNA editing liver therapy Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search Vasa Therapeutics to presen... New CTO joins Rokit
Cancer blood test maker Grail files for Nasdaq IPO - Longevity.Technology Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search Vasa Therapeutics t
Leonard Hayflick, PhD Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search FDA approves new therapy fo... ŌURA’s smallest smart... Rubedo re
First Longevity: announcing our premier league Advisory Panel - Longevity.Technology Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search New CTO … ogy from the University of Pittsburgh before completing a Research and Clinical Fellowship in the Department of Psychiatry at Harvard Medical School. Dmitry Kaminskiy Managing Partner, Deep Knowledge Ventures , Longevity.Capital Dmitry Kaminskiy is an innovative entrepreneur and investor active in the fields of Longevity, Precision Medicine, and Artificial Intelligence. He is co-founder and managing partner at Deep Knowledge Ventures, a leading investment fund focused on Deep … Longevity cooperation development division. Deep Knowledge Ventures Investment Fund and its analytical subsidiary Deep Knowledge Analytics are particularly active in the AI for Drug Discovery sector, starting with its 2014 seed investment in industry leader Insilico Medicine. Aging Analytics Agency is the Longevity-focused analytical subsidiary of Deep Knowledge Ventures, and currently serves as the Longevity, Preventive Precision Medicine and Economics of Aging data an
Roche trial seeks to prevent Alzheimer’s in at-risk patients Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search Vasa Therapeutics to presen... N
Alzheimer's drug donanemab Phase 3 data announced Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search FDA approves new therapy fo... ŌURA
Advantage lands NIA funding to advance Alzheimer’s drug Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search Vasa Therapeutics to presen... New CT … apeutics has secured a $2.5 million Phase II Small Business Innovation Research grant from the National Institute on Aging to advance its Alzheimer’s disease candidate AD04. The Miami-based biotech is preparing to launch confirmatory Phase 2b clinical trials in Europe to evaluate the therapy’s safety and efficacy in early-stage patients. With a long history of use as a vaccine adjuvant in both human and animal programs, Advantage is repurposing AD04 as a new class of Alzheime … ), which provides conditional approval after Phase 2 studies. Commenting on the grant funding, Advantage CEO Jeffrey Madden, said: “This award positions us to accelerate regulatory momentum and attract the strategic partners required for broad patient access.” AD04 functions as an immunomodulator, regulating the immune system to reduce disease pathology rather than directly targeting amyloid beta or tau proteins. Its activity has been linked to restoration of genes involved i
Summit to target translation of longevity science Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search Vasa Therapeutics to presen... New CTO join … glycan profiling, epigenetic clocks and senotherapeutics, and their real-world application in patient care. Longevity.Technology: With longevity events proliferating at pace, it’s increasingly difficult for any single summit to rise above the noise – yet this new alliance between the Global Longevity Summit and A4M does so through focus rather than flash. By zeroing in on the translational frontier – where breakthrough science meets clinical application – and drawing on A4M’
AI’s role in the next era of longevity biotech Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search FDA approves new therapy fo... ŌURA’s sm
Rejuvenation Startup Summit 2024 reveals full speaker list Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search Vasa Therapeutics to presen... New … bsp; Healthy Longevity Clinic and Managing Partner of LongevityTech.fund Brian Kennedy, Professor at NUS Singapore Eric Verdin, CEO and president of the Buck Institute for Research on Aging Investors on stage: Jens Eckstein, Investment Partner at Hevolution Alex Colville, Co-founder, General Partner at Age1 Jan Adams, Partner at Apollo Health Ventures Sergey Jakimov, Managing Partner at LongeVC Marc P Bernegger, Founding Partner
Phil Newman to speak at Rejuvenation Startup Summit 2024 Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search Vasa Therapeutics to presen... New C … Sramek – Co-Founder Healthy Longevity Clinic and Managing Partner LongevityTech.fund The RSS will showcase an exciting range of presentations from CEOs of startups in the fields of rejuvenation and longevity, an all-day startup forum for networking, panel discussions and keynote presentations. Starting midday on Friday and finishing off on Saturday night with a party for all attendees, the summit offers ample opportunity to connect with some of the most promising leaders in t
--> Rejuvenation Startup Summit Archives - Longevity.Technology Log in or apply to view this content. Login Apply Oops! We could not locate your form. Annual longevity investment report 2023 Purchase report $59.99 Purchase report $59.99 Login to read (requires purchase) First half longevity investment report 2024 Purchase report $29.99 Purchase report $29.99 Login to read (requires purchase) Feedback Store News Lifestyle Events --> About Contact Advertise --> About Contact Advertise News Investment Clinics Search for: Search News Home Biotech Investment Diagnostics Agetech Supplements Innovati
Rejuvenation Startup Summit 2024 announces first set of speakers Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search FDA approves new therapy fo. … Cofounder of the Healthy Longevity Clinic and Managing Partner of LongevityTech.fund Brian Kennedy , Professor at NUS Singapore Eric Verdin , CEO and president of the Buck Institute for Research on Aging Investors on stage include: Jens Eckstein , Investment Partner at Hevolution Alex Colville , Cofounder, General Partner at Age1 Jan Adams , Partner at Apollo Health Ventures Sergey Jakimov , Managing Partner at LongeVC Marc P Bernegger , Founding Partner at Maximon Patr
Why LongBio is poised for a breakout at JPM 2026 Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search Vasa Therapeutics to presen... New CTO joins … g rhino.fi, one of the world’s leading blockchain bridges, as well as a venture fund, ZKV, which has built a portfolio of more than 30 frontier tech cryptography investments. An active angel investor with a personal passion for longevity, Will holds both a BA and MEng in Manufacturing Engineering from the University of Cambridge. DISCLOSURE: Will Harborne is an investor in First Longevity Limited (Longevity.Technology is a brand of First Longevity Limited). Guest contributor
Vitalist Bay 2026 set to spotlight longevity’s next phase Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search Vasa Therapeutics to presen... New
A new beacon for longevity innovation and collaboration Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search Vasa Therapeutics to presen... New CT … collaboration. This event is set to foster reflection, connection and practical application, and with its emphasis on co-living and health optimization, Vitalist Bay exemplifies a broader cultural and scientific commitment to reshaping how we approach aging – not only talking the talk but living the life. The organizers, the Vitalism Foundation, have positioned Vitalist Bay as a focal point for the longevity community, describing it as “history’s most concentrated ecosystem o
Longevity Investors Conference returns to Gstaad in September Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search FDA approves new therapy fo... … ger view. For more information on the Longevity Investors Conference 2025 or to apply, please CLICK HERE . Photographs courtesy of Longevity Investors Conference Lt Wire FDA approves new therapy for high-risk bladder cancer ŌURA’s smallest smart ring launched with expanded health monitoring Rubedo reports promising early trial results for anti-aging skin cream Aeon Clinic brings cellular optimization and NAD+ IV drips to Dubai Elysium launches physician-led longevity pr
'The more unashamedly we talk about radical life extension, the better' Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search Vasa Therap
RAADfest 2023: It's time to meet your future face-to-face Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search Vasa Therapeutics to presen...
GLP-1s claim the longevity stage at ARDD Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search Vasa Therapeutics to presen... New CTO joins Rokit H
ARDD 2026 to relocate to Boston Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search New CTO joins Rokit Healthc... MitoRx’s new obesity ...